Online citations, reference lists, and bibliographies.
← Back to Search

Probiotics: History And Evolution

V. Gogineni, L. Morrow, P. Gregory, M. Malesker
Published 2013 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Probiotics are viable microbial species, which are ingested for the purpose of altering the gastrointestinal flora in a manner, which confers health benefits. Currently available probiotic products include a wide array of bacterial and fungal species which are consumed in a variety of preparations. The use of microbials originated (unintentionally) centuries ago when people first noted the beneficial health effects of eating fermented foods. Modern probiotic-containing foods and products are the direct derivatives of these early fermented foods. The use of fermented milk and yogurt are the part of human history and their role has been with humanity, to date, between legends and historical data [1]. The present review outlines the origins of probioticcontaining foods and our subsequent refinement of these biologic agents.
This paper references
Mèmoire sur la fermentation appeleé lactique
L Pasteur (1858)
10.1038/022189a0
The Sacred Books of the East
A. H. Sayce (1880)
Tratement des infections intestinales par la méthode de la flore bactérienne de l’intestin
H Tissier (1906)
Tratement des infections intestinales par la méthode de la flore bactérienne de l’intestin
H Tissier (1906)
[The increase of the diseases of civilization and their prevention].
W. Kollath (1953)
10.1126/science.147.3659.747
Probiotics: Growth-Promoting Factors Produced by Microorganisms
Daniel M. Lilly (1965)
The other half of the antibiotic story
RB Parker (1974)
Le strategie alimentari nella preistoria
C Perles (1977)
Le strategie alimentari nella preistoria
C Perles (1977)
Le strategie alimentari nella preistoria In
C Perles (1977)
Fermented protein foods in the Orient, with emphasis on Shoyu and Miso in Japan
T Yokotsuka (1985)
Ancient Records of Egypt
J. H. Breasted (1988)
10.1016/0016-5085(89)91613-2
Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study.
C. Surawicz (1989)
10.1097/00006676-199101001-00007
Organ Failure and Multiple Organ System Failure in Pancreatitis
D. Mcfadden (1991)
10.1093/JN/125.6.1401
Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics.
G. Gibson (1995)
Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo.
L. Mcfarland (1995)
10.1128/iai.64.12.5225-5232.1996
Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum
I. Castagliuolo (1996)
Cheese and fermented milk foods-Origins and Principles
F Kosikowski (1997)
Cheese and fermented milk foods-Origins and Principles, Westport CT USA
F Kosikowski (1997)
10.1099/00222615-47-7-591
Bacterial translocation, intestinal microflora and morphological changes of intestinal mucosa in experimental models of Clostridium difficile infection.
P. Naaber (1998)
10.1016/S0163-4453(98)92448-3
The lack of therapeutic effect of Saccharomyces boulardii in the prevention of antibiotic-related diarrhoea in elderly patients.
S. Lewis (1998)
10.1016/S0140-6736(98)06343-0
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial
B. Rembacken (1999)
10.1152/ajpgi.1999.276.4.G941
Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression.
D. Mack (1999)
10.1016/S0022-3476(99)70053-3
Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children.
J. Vanderhoof (1999)
10.1542/peds.104.5.e64
Prophylactic Lactobacillus GGReduces Antibiotic-Associated Diarrhea in Children With Respiratory Infections: A Randomized Study
T. Arvola (1999)
10.1086/318130
The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii.
C. Surawicz (2000)
10.1046/J.1471-5740.2001.00006.X
Cambridge World History of Food
K. Kiple (2000)
10.4065/76.9.883
Lack of effect of Lactobacillus GG on antibiotic-associated diarrhea: a randomized, placebo-controlled trial.
M. R. Thomas (2001)
10.1016/S0958-6946(01)00036-X
Yogurt as probiotic carrier food
A. Lourens-Hattingh (2001)
10.1016/S0140-6736(00)04233-1
Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial
S. Kenyon (2001)
10.1128/IAI.69.4.2762-2765.2001
Saccharomyces boulardii Stimulates Intestinal Immunoglobulin A Immune Response to Clostridium difficileToxin A in Mice
A. Qamar (2001)
10.1097/00006254-200109000-00007
Broad-Spectrum Antibiotics for Preterm, Prelabour Rupture of Fetal Membranes: The ORACLE I Randomised Trial
S. Kenyon (2001)
10.1080/089106001750462669
The Host Genotype Affects the Bacterial Community in the Human Gastrointestinal Tract
E. Zoetendal (2001)
10.1097/00075198-200210000-00009
Nosocomial pneumonia: emerging concepts in diagnosis, management, and prophylaxis
D. Craven (2002)
10.1046/J.1365-2168.2002.02189.X
Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis
A. Olah (2002)
10.1079/BJN2003954
Some insights into the derivation and early uses of the word ‘probiotic’
J. Hamilton-miller (2003)
10.2436/IM.V7I1.9445
Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea.
S. Plummer (2004)
10.1097/01.CCM.0000128569.09113.FB
Prevention of hospital-associated pneumonia and ventilator-associated pneumonia
M. Kollef (2004)
10.1186/1471-230X-4-5
Lactobacillus GG in inducing and maintaining remission of Crohn's disease
M. Schultz (2004)
10.1023/A:1010786701289
Acute Pancreatitis and Bacterial Translocation
L. Cicalese (2004)
[Captain Cook used sauerkraut to prevent scurvy].
P. Saloheimo (2005)
10.1097/00005176-200505000-00048
Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea in children: a randomized double-blind placebo-controlled trial.
M. Kotowska (2005)
10.1111/j.1365-2036.2005.02356.x
Saccharomyces boulardii in the prevention of antibiotic‐associated diarrhoea in children: a randomized double‐blind placebo‐controlled trial
M. Kotowska (2005)
10.1097/01.CCM.0000181731.53912.D9
Clinical and economic consequences of ventilator-associated pneumonia: A systematic review
N. Safdar (2005)
10.1051/LAIT:2004026
Technological aspects related to the use of bifidobacteria in dairy products
Denis Roy (2005)
10.1042/BST0331078
Signalling role of adipose tissue: adipokines and inflammation in obesity.
P. Trayhurn (2005)
Probiotics in human health : A current assessment
V. C. Suvama (2005)
What is ventilator-associated pneumonia and why is it important?
M. Kollef (2005)
10.1164/rccm.200405-644st
Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.
古谷 良輔 (2005)
10.1097/01.MIB.0000175905.00212.2c
A Randomized, Double‐blind Trial of Lactobacillus GG Versus Placebo in Addition to Standard Maintenance Therapy for Children with Crohn's Disease
A. Bousvaros (2005)
10.1136/gut.2005.076604
Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial
P. Marteau (2006)
Prophylactic Saccharomyces boulardii in the prevention of antibiotic-associated diarrhea: a prospective study.
M. Can (2006)
10.1097/01.qco.0000224823.73223.29
Probiotics and neonatal intestinal infection
C. Hammerman (2006)
Differences in feal microbiota in different European study populations in relation to age, gender, and country: A cross-sectional study
S Meuller (2006)
10.1152/AJPENDO.00302.2006
Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes.
S. Creely (2007)
10.3748/WJG.V13.I19.2733
Comparison of early enteral nutrition in severe acute pancreatitis with prebiotic fiber supplementation versus standard enteral solution: a prospective randomized double-blind study.
T. Karakan (2007)
10.1016/S0140-6736(07)60748-X
Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials
G. Deshpande (2007)
Synbiotic control of inflammation and infection in severe acute pancreatitis: a prospective, randomized, double blind study.
A. Oláh (2007)
10.1136/bmj.39231.599815.55
Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial
M. Hickson (2007)
10.1152/AJPGI.00024.2006
Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis.
P. Brun (2007)
Adjuvant therapy for probiotics in patients with severe acute pancreatitis: An analysis of 14 cases
YM Li (2007)
10.1097/MCO.0b013e3282f2bfdf
The inflammatory status of old age can be nurtured from the intestinal environment
Y. Guigoz (2008)
10.1016/S0140-6736(08)60207-X
Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial
M. Besselink (2008)
10.1002/14651858.CD005496.pub2
Probiotics for prevention of necrotizing enterocolitis in preterm infants.
K. Alfaleh (2008)
10.1093/AJCN/87.5.1219
Energy intake is associated with endotoxemia in apparently healthy men.
J. Amar (2008)
10.1017/S0029665108006290
Gut microbes and obesity in adolescents
M. Sotos (2008)
10.1093/AJCN/87.3.534
Early differences in fecal microbiota composition in children may predict overweight.
M. Kalliomäki (2008)
10.1038/sj.ejcn.1602792
Effect of Lactobacillus plantarum enteral feeding on the gut permeability and septic complications in the patients with acute pancreatitis
H-L Qin (2008)
10.1016/S0016-5085(08)61677-7
M1202 Effective Probiotic Treatment (VSL#3), But Not Placebo, in Acute Ulcerative Colitis Is Associated with Down-Regulation of Inflammatory Intestinal Dendritic Cells
Siew C Ng (2008)
10.1007/s00112-008-1830-8
Probiotika bei Frühgeborenen
W. Mihatsch (2008)
10.1038/sj.ejcn.1602718
Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink
C. Wenus (2008)
Probiotics in man and animals
R. (2008)
10.1542/peds.2007-3007
Oral Probiotics Prevent Necrotizing Enterocolitis in Very Low Birth Weight Preterm Infants: A Multicenter, Randomized, Controlled Trial
Hung-Chih Lin (2008)
The probiotics market: Ingredients, supplements, foods
R Agheyisi (2008)
The probiotics market: Ingredients, supplements, foods, Report code: FOD035B
R Agheyisi (2008)
10.1097/MCC.0b013e3283220e78
Ventilator-associated pneumonia
M. Valencia (2009)
10.1177/0148607108331176
Comment on: probiotic prophylaxis in predicted severe acute pancreatitis: a randomized, double-blind, placebo-controlled trial.
S. Mcclave (2009)
10.1038/nrgastro.2009.35
Principles and clinical implications of the brain–gut–enteric microbiota axis
S. Rhee (2009)
10.1038/ajg.2009.25
The Utility of Probiotics in the Treatment of Irritable Bowel Syndrome: A Systematic Review
D. Brenner (2009)
10.1542/peds.2007-3423
Prolonged Duration of Initial Empirical Antibiotic Treatment Is Associated With Increased Rates of Necrotizing Enterocolitis and Death for Extremely Low Birth Weight Infants
C. M. Cotten (2009)
10.1073/pnas.0812600106
Human gut microbiota in obesity and after gastric bypass
Husen Zhang (2009)
The effect of a new symbiotic formulation on plasma levels and peripheral blood mononuclear cell expression of some pro-inflammatory cytokines in patients with ulcerative colitis: a pilot study.
A. Federico (2009)
10.1038/nature07540
A core gut microbiome in obese and lean twins
P. Turnbaugh (2009)
Adjuvant therapy for probiotics in patients with severe acute pancreatitis with hepatic lesion: an analysis of 27 cases
XG Wu (2009)
10.1038/ijo.2010.50
The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years
R. Luoto (2010)
10.1016/j.ijfoodmicro.2010.04.017
Functional intestinal microbiome, new frontiers in prebiotic design.
M. Candela (2010)
10.1136/bmj.c77
Dutch probiotics study is criticised for its “design, approval, and conduct”
T. Sheldon (2010)
10.3748/WJG.V16.I18.2202
Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.
L. Mcfarland (2010)
10.1007/s10620-010-1276-4
Abnormal Breath Testing in IBS: A Meta-Analysis
E. Shah (2010)
Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor
M Vijay-Kumar (2010)
10.1002/emmm.201100159
Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment
J. Amar (2011)
10.1016/j.gtc.2010.12.007
Symptom-based diagnostic criteria for irritable bowel syndrome: the more things change, the more they stay the same.
P. Moayyedi (2011)
10.3945/ajcn.110.010132
Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans.
R. Jumpertz (2011)
10.1126/science.1208344
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
Gary D. Wu (2011)
10.2752/175169711X12900033260565
Uncorking the Past: The Quest for Wine, Beer, and Other Alcoholic Beverages
J. Walklate (2011)
10.1038/ajg.2010.371
The Incidence and Gastrointestinal Infectious Risk of Functional Gastrointestinal Disorders in a Healthy US Adult Population
C. Porter (2011)
PROBIOTICS , PREBIOTICS AND SYNBIOTICS
Sweta V. Chauhan (2012)
10.1186/cc11398
Probiotics' effects on the incidence of nosocomial pneumonia in critically ill patients: a systematic review and meta-analysis
Kai-xiong Liu (2012)
10.1016/J.YPED.2010.12.040
Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5
J. Stockman (2012)
Probiotics: History and Evolution
CM Surawicz (2013)
10.1111/hex.12027
‘Someone should oversee it’: patient perspectives on the ethical issues arising with the regulation of probiotics
K. Harrison (2015)
Discourses: Biological & Geological (volumeVIII): Yeast
A Huxley
Axon AT (1999) Nonpathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial
B J Rembacken



This paper is referenced by
10.3389/fimmu.2021.616713
Modulatory Effects of Probiotics During Pathogenic Infections With Emphasis on Immune Regulation
A. Raheem (2021)
10.3389/fmicb.2021.658943
The Tetracycline Resistance Gene, tet(W) in Bifidobacterium animalis subsp. lactis Follows Phylogeny and Differs From tet(W) in Other Species
Katrine Nøhr-Meldgaard (2021)
10.1016/J.ENZMICTEC.2021.109836
A review on enzyme-producing lactobacilli associated with the human digestive process: From metabolism to application.
B. L. Maske (2021)
10.1016/B978-0-12-818588-9.00005-X
Probiotic beverages in Japan (some history and current developments)
H. Sugahara (2021)
10.1007/s00580-020-03175-z
The effects of treatments with multistrain probiotics on serum aminotransferases, AST-ALT ratio, body weight and survivability scores of rats experimentally infected with Trypanosoma brucei
C. C. Okolo (2020)
10.3390/ijms21082890
Microbial Medicine: Prebiotic and Probiotic Functional Foods to Target Obesity and Metabolic Syndrome
Miranda Green (2020)
10.31134/AP.91.1.6
Uso de probióticos en el tratamiento y laprevención de diarrea aguda en niños
Karina Machado (2020)
10.1016/j.fgb.2020.103333
Yeasts as probiotics: mechanisms, outcomes, and future potential.
Swastik Sen (2020)
10.21307/pm-2020.59.1.004
SACCHAROMYCES CEREVISIAE VAR. BOULARDII IN IRRITABLE BOWEL SYNDROME
P. Gałązka (2020)
10.4103/jiaphd.jiaphd_88_19
A systematic review of randomized trials on effects of probiotic on oral Candida
S. Shah (2020)
10.1007/978-3-030-42319-3_10
Prebiotics, Probiotics, Synbiotics and Its Importance in the Management of Diseases
S. Palai (2020)
10.1080/14787210.2019.1645597
A successful history: probiotics and their potential as antimicrobials
L. Santacroce (2019)
10.1007/978-981-13-8315-1_18
Mining Human Microbiome for Therapeutics
Vikas C. Ghattargi (2019)
10.1007/978-3-319-98464-3_13
Therapeutic Targeting of Gut-Bone Signaling to Treat Osteoporosis
L. McCabe (2019)
10.3390/microorganisms7090279
Microbiota and Immune-Mediated Skin Diseases—An Overview
A. Catinean (2019)
Antioxidant Activity of Probiotics in Yogurt Drinks During Storage Condition
Darshieny Nadarason (2018)
10.1007/s00223-018-0403-7
Advances in Probiotic Regulation of Bone and Mineral Metabolism
L. McCabe (2018)
10.1002/9781119380924.CH3
Effect of Probiotics on Reproductive Health
P. Kochan (2018)
10.1111/jgh.13840
The role of the microbiome and the use of probiotics in gastrointestinal disorders in adults in the Asia‐Pacific region ‐ background and recommendations of a regional consensus meeting
U. Ghoshal (2018)
10.1007/978-3-319-71950-4_1
Probiotics and Prebiotics: An Overview on Recent Trends
G. Zoumpopoulou (2018)
10.3390/foods7020013
The Role of Bacteria, Probiotics and Diet in Irritable Bowel Syndrome
Ashton J Harper (2018)
10.4103/ijohs.ijohs_10_18
Probiotics and periodontal disease
Anjhana Asok (2018)
10.1007/978-981-13-1123-9_23
Importance of Probiotics in Human Health
D. Banerjee (2018)
'Lactobacillus fermentum' 3872 genome sequencing and analysis
B. Lehri (2017)
10.1007/978-3-319-66653-2_11
Probiotics in Gut-Bone Signaling.
J. Schepper (2017)
10.9790/264X-03022833
Bacteriocin: Promising Natural Antimicrobials from Probiotic Bacillus subtilis
Bholay A.D (2017)
10.1016/j.freeradbiomed.2016.12.015
Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health
C. Koch (2017)
10.21276/AIMDR.2016.2.5.DE3
Benefits of Probiotics in Oral cavity - A Detailed Review.
D. Pandya (2016)
10.21276/SAJB.2016.4.6.18
A Review on Probiotics
J. Dutta (2016)
10.4172/2476-2059.1000111
Patents in the Field of Probiotics, Prebiotics, Synbiotics: A Review
Y. Dixit (2016)
An investigation of optimal feeding ration and effects of probiotic bacteria on the growth of New Zealand Abalone (Haliotis iris)
Te Rerekohu Tuterangiwhiu (2015)
TÉCNICAS PARA LA MICROENCAPSULACIÓN DE PROBIÓTICOS Y EL IMPACTO EN SU FUNCIONALIDAD: UNA REVISIÓN
U. NataliaDeAraújo (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar